FGF21 and obesity due to melanocortin 4 receptor deficiency: Previous studies have shown that administration of Fgf21 can lower triglyceride levels in genetic models of obesity [59], can reduce ceramide levels in obese animals [60] and attenuate hyperglycemia in diabetic mice [61].